TD SYNNEX Corporation header image

TD SYNNEX Corporation

SNX

Equity

ISIN US87162W1009 / Valor 1676033

New York Stock Exchange, Inc (2024-11-19)
USD 114.71-1.37%

TD SYNNEX Corporation
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

TD SYNNEX Corporation is a global leader in IT distribution and services, providing a broad range of products and solutions to customers around the world. The company operates at the intersection of technology and business, leveraging its extensive expertise in areas such as cloud computing, security, data analytics, and the Internet of Things (IoT) to drive innovation and deliver value to its partners and clients. With a strategic focus on next-generation technologies, TD SYNNEX is committed to facilitating the digital transformation journey of businesses across various industries. The leadership team, including Chief Strategy Officer Sergio Farache and Chief Business Officer Simon Leung, plays a pivotal role in steering the company's growth through strategic initiatives, mergers and acquisitions, and a comprehensive approach to risk management and corporate communications. Under the guidance of Chief Human Resources Officer Beth Simonetti, TD SYNNEX also emphasizes the importance of talent management, diversity, equity, and inclusion, and corporate social responsibility, ensuring a sustainable and forward-looking approach to business.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (14.08.2024):

Revenue

TD SYNNEX Corporation reported revenue of $13.9 billion for the fiscal second quarter of 2024, which is within their outlook range of $13.3 to $14.9 billion. This represents a slight decrease of 0.8% compared to the same quarter in the previous year.

Net Income

The net income for TD SYNNEX Corporation in the fiscal second quarter of 2024 was $144 million. On a non-GAAP basis, the net income was $237 million, which falls within the company's outlook for the quarter.

Earnings Per Share

TD SYNNEX Corporation reported diluted earnings per share (EPS) of $1.66 for the fiscal second quarter of 2024. On a non-GAAP basis, the diluted EPS was $2.73, aligning with the company's projected outlook.

Shareholder Returns

In the fiscal second quarter of 2024, TD SYNNEX Corporation returned $288 million to shareholders. This included $254 million in share repurchases and $34 million in dividends, marking a 210% increase from the prior fiscal second quarter.

Dividend Announcement

TD SYNNEX Corporation announced a quarterly cash dividend of $0.40 per common share for the fiscal second quarter of 2024. This represents a 14% increase from the dividend declared in the prior fiscal second quarter.

Summarized from source with an LLMView Source

Key figures

16.8%1Y
0.65%3Y
95.6%5Y

Performance

24.0%1Y
28.0%3Y
36.4%5Y

Volatility

Market cap

11120 M

Market cap (USD)

Daily traded volume (Shares)

101,029

Daily traded volume (Shares)

1 day high/low

115.97 / 114.43

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

TeamViewer SE
TeamViewer SE TeamViewer SE Valor: 50049146
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.34%EUR 11.76
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC Centessa Pharmaceuticals PLC Valor: 111275225
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.53%USD 16.74
NanoRepro AG
NanoRepro AG NanoRepro AG Valor: 4691951
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%EUR 1.57
Furukawa Denki Kogyo KK
Furukawa Denki Kogyo KK Furukawa Denki Kogyo KK Valor: 761866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.46%JPY 6,055.00
reAlpha Tech Corp
reAlpha Tech Corp reAlpha Tech Corp Valor: 126516341
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.05%USD 1.01
Entain PLC
Entain PLC Entain PLC Valor: 11238866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.61%GBP 7.50
KK DeNA
KK DeNA KK DeNA Valor: 2045354
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%JPY 2,469.00
JinkoSolar Holding Co Ltd
JinkoSolar Holding Co Ltd JinkoSolar Holding Co Ltd Valor: 11035900
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.70%USD 20.82
Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc Vertex Pharmaceuticals Inc Valor: 983327
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.72%USD 451.23
MercadoLibre Inc
MercadoLibre Inc MercadoLibre Inc Valor: 3109814
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.77%USD 1,931.26